Rose Nyirenda

Datos Biográficos

ID7726515
NOMBRERose Nyirenda
NOMBRESRose
APELLIDONyirenda
FIRMANYIRENDA R
AFILIACIONESMinistry of Health
VERIFICADONo
TOTAL DE OBRAS14
TOTAL DE CITAS0
TOTAL COMO AUTOR14
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study)

    Open AccessKate Shearer, Bareng A S Nonyane et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: While highly effective for reducing the risk of tuberculosis (TB) disease, TB preventive treatment (TPT) is underused among people living with HIV (PWH). We evaluated the effectiveness of a behavioural economics-based choice architecture approach to increase facility-level TPT prescribing to PWH in Malawi, Mozambique and Zimbabwe. METHODS: We conducted a cluster-randomised trial within the IMPAACT4TB 3HP rollout, in which 57 healthc…

  • A health systems approach to more effective decentralised HIV prevention

    Open AccessGift Kawalazira, Yohane Kamgwira et al.ARTICLEBMJ Global Health2025

    Achieving global targets to end the HIV/AIDS epidemic as a public health threat by 2030 and beyond requires enhanced health system capacity for HIV prevention at national and subnational levels. Specifically, this system’s capacity must enable countries to reach high-risk populations effectively, systematically engage communities to generate demand for HIV prevention services, build diverse delivery channels to meet this demand and address struct…

  • Impact of an optimized care model for advanced HIV disease

    Open AccessThulani Maphosa, Lise Denoeud‐Ndam et al.ARTICLEBMC Public Health2025

    Our study underscores the vital role of improving screening and diagnostic efforts for advanced HIV disease (AHD), notably targeting AHD-related opportunistic infections, including TB and Cryptococcal diseases. Word count: 4,832 words, excluding references

  • Stakeholder priorities for ART initiation and early retention strategies in Malawi

    Open AccessSanthi Hariprasad, Khumbo Phiri et al.ARTICLEBMC Public Health2025

    New or returning antiretroviral therapy (ART) clients are largely ineligible for differentiated service delivery (DSD) models. These clients are at increased risk of treatment interruption and may benefit from flexible care models, but stakeholder buy-in may limit progress on interventions for this population. We qualitatively explored stakeholder perceptions and decision-making criteria for scaling DSD models for new or returning ART clients in …

  • Enhancing Sars-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022

    Open AccessGodfrey Woelk, Thulani Maphosa et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: Monitoring the SARS-CoV-2 pandemic in low-resource countries such as Malawi requires cost-effective surveillance strategies. This study explored the potential utility of phone-based syndromic surveillance in terms of its reach, monitoring trends in reported SARS-CoV-2-like/influenza-like symptoms (CLS/ILS), SARS-CoV-2 testing and mortality. METHODS: Mobile phone-based interviews were conducted between 1 July 2020 and 30 April 2022, …

  • HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia

    Open AccessOlanrewaju Edun, Lucy Okell et al.ARTICLEPLOS Global Public Health2024

    As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV programmes require up-to-date information about evolving HIV risk behaviour and transmission risk, including those with low-level viremia (LLV; >50 to ≤1000 copies/mL), to guide prevention priorities. We aimed to assess differences in sexual risk behaviours, distribution of viral load (VL) and proportion of transmission across PLHIV subgroups. We analysed…

  • Evaluating the impact of HIV pre-exposure prophylaxis on pregnancy, infant, and maternal health outcomes in Malawi

    Open AccessFriday Saidi, Sanya Shah et al.ARTICLEBMC Public Health2024

    NCT06158126. The study was prospectively registered (5 December 2023) in ClinicalTrials.gov

  • Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi

    Open AccessLucky Makonokaya, Alice Maida et al.ARTICLEAIDS and Behavior2024

    Viral suppression (VS) in children has remained suboptimal compared to that in adults. We evaluated the impact of transitioning children weighing < 20 kg to a pediatric formulation of dolutegravir (pDTG) on VS in Malawi. We analyzed routine retrospective program data from electronic medical record systems pooled across 169 healthcare facilities in Malawi supported by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF). We included children who…

  • Understanding gender differences of people with HIV newly diagnosed or returning to care with advanced HIV disease in Malawi

    Open AccessLeila Katirayi, Thulani Maphosa et al.ARTICLEBMC Public Health2023

    NCT05510973, first registration 22/08/2022

  • Catalyzing action on HIV/SRH integration

    Open AccessJanet Fleischman, Fannie Kachale et al.ARTICLEGlobal Health Action2022

    The HIV pandemic has long revealed the inequities and fault lines in societies, one of the most tenacious being the pandemic's disproportionate impact on adolescent girls and young women. In east and southern Africa, renewed global action is needed to invigorate an effective yet undervalued approach to expanding HIV prevention and improving women's health: integration of quality HIV and sexual and reproductive health (SRH) services. The urgency o…

  • Effect of door-to-door distribution of HIV self-testing kits on HIV testing and antiretroviral therapy initiation

    Open AccessPitchaya Indravudh, Katherine Fielding et al.ARTICLEBMJ Global Health2021

    INTRODUCTION: Reaching high coverage of HIV testing remains essential for HIV diagnosis, treatment and prevention. We evaluated the effectiveness and safety of door-to-door distribution of HIV self-testing (HIVST) kits in rural Malawi. METHODS: This cluster randomised trial, conducted between September 2016 and January 2018, used restricted 1:1 randomisation to allocate 22 health facilities and their defined areas to door-to-door HIVST alongside …

  • Pragmatic economic evaluation of community-led delivery of HIV self-testing in Malawi

    Open AccessPitchaya Indravudh, Katherine Fielding et al.ARTICLEBMJ Global Health2021

    INTRODUCTION: Community-based strategies can extend coverage of HIV testing and diagnose HIV at earlier stages of infection but can be costly to implement. We evaluated the costs and effects of community-led delivery of HIV self-testing (HIVST) in Mangochi District, Malawi. METHODS: This economic evaluation was based within a pragmatic cluster-randomised trial of 30 group village heads and their catchment areas comparing the community-led HIVST i…

  • Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in Malawi

    Open AccessScott A Nabity, Kelvin Mponda et al.ARTICLEFrontiers in Public Health2020

    Background: Pellagra is caused by niacin (vitamin B3) deficiency and manifested by a distinctive dermatitis. Isoniazid is critical for treating tuberculosis globally and is a component of most regimens to prevent tuberculosis. Isoniazid may contribute to pellagra by disrupting intracellular niacin synthesis. In 2017, Malawian clinicians recognized a high incidence of pellagra-like rashes after scale-up of isoniazid preventive treatment (IPT) to p…

  • Vital Start

    Open AccessMaria H Kim, Saeed Ahmed et al.ARTICLEAIDS and Behavior2019